Metastatic Breast Cancer: hormone-dependent - New Study Results

Breast Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Erika HamiltonПодробнее

Metastatic Hormone Positive Breast Cancer | 2023 KU Breast Cancer Year in Review ConferenceПодробнее

Updates in Systemic Therapy for Breast Cancer 2/8/23Подробнее

2023 Updates In Metastatic Breast Cancer TreatmentПодробнее

What are CDK 4/6 Inhibitors for Breast Cancer?Подробнее

Metastatic Breast Cancer | 2022 OneOncology ConferenceПодробнее

Navigating the Expanding Treatment Arsenal for ER+/HER2- Breast CancerПодробнее

2022 KU Post San Antonio Review | Early-Stage Hormone + Breast Cancer: Optimizing Systemic TherapyПодробнее

What's New and on the Horizon for Metastatic Breast Cancer?Подробнее

New Research in Metastatic Breast Cancer | SABCS 2019Подробнее

ER-Positive Breast Cancer: What's New in Treatment and Research at MBC Patient Forum 2019Подробнее

BCFNZ Webinar: Palbociclib (Ibrance) for advanced or metastatic HR+ breast cancer - NZ updateПодробнее

Clinical Experience: CDK4/6 Inhibitors in Breast CancerПодробнее

New Data on CDK 4/6 Inhibitors: An Update From SABCS 2016Подробнее

New Data and New Drugs for Metastatic Breast Cancer - Recommendations by Patient Subtype.mp4Подробнее

Mechanistic Activity and Development History of CDK 4/6 InhibitorsПодробнее

Expert Perspectives: CDK 4/6 Inhibitors for ER+ Breast Cancer: Current Data and Clinical UseПодробнее

Advanced Hormone Receptor-positive Breast CancerПодробнее

Hormone Positive (ER+/PR) MBC - Dr. Katie Reeder Hayes - 2014 MBCN Conference at UNCПодробнее